Amanda A. Hill

964 total citations
17 papers, 638 citations indexed

About

Amanda A. Hill is a scholar working on Molecular Biology, Immunology and Physiology. According to data from OpenAlex, Amanda A. Hill has authored 17 papers receiving a total of 638 indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Molecular Biology, 9 papers in Immunology and 4 papers in Physiology. Recurrent topics in Amanda A. Hill's work include Phagocytosis and Immune Regulation (8 papers), Erythrocyte Function and Pathophysiology (3 papers) and Chronic Myeloid Leukemia Treatments (3 papers). Amanda A. Hill is often cited by papers focused on Phagocytosis and Immune Regulation (8 papers), Erythrocyte Function and Pathophysiology (3 papers) and Chronic Myeloid Leukemia Treatments (3 papers). Amanda A. Hill collaborates with scholars based in United States, Germany and Canada. Amanda A. Hill's co-authors include Graydon S. Meneilly, Kelly D. Sullivan, Joaquı́n M. Espinosa, Matthew D. Galbraith, Ahwan Pandey, James DeGregori, Leisa Jackson, Eliana B Gómez, L. Alexander Liggett and Joseph Cabral and has published in prestigious journals such as Blood, Cancer Research and Oncogene.

In The Last Decade

Amanda A. Hill

16 papers receiving 634 citations

Peers

Amanda A. Hill

IMMUN

PHEOH

PHYSI

ONCOL

Tobias Strid Sweden

Yang Xiang China

Shlomit Kfir‐Erenfeld Israel

Mamdouh H. Kedees United States

Nam-Ho Choi-Miura Japan

Shu‐Rung Lin Taiwan

Rui Zhong United States

Kerstin Kirchhoff Germany

Zoë Fonseca-Kelly United States

Berta N. Vázquez Spain

Tobias Strid Sweden

Amanda A. Hill

414 ×1.8

319 ×1.4

IMMUN

77 ×0.6

PHEOH

64 ×0.6

PHYSI

138 ×1.7

ONCOL

Citations per year, relative to Amanda A. Hill Amanda A. Hill (= 1×) peers Tobias Strid

Countries citing papers authored by Amanda A. Hill

Since Specialization

Citations

This map shows the geographic impact of Amanda A. Hill's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Amanda A. Hill with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Amanda A. Hill more than expected).

Fields of papers citing papers by Amanda A. Hill

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Amanda A. Hill. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Amanda A. Hill. The network helps show where Amanda A. Hill may publish in the future.

Co-authorship network of co-authors of Amanda A. Hill

This figure shows the co-authorship network connecting the top 25 collaborators of Amanda A. Hill. A scholar is included among the top collaborators of Amanda A. Hill based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Amanda A. Hill. Amanda A. Hill is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

17 of 17 papers shown

Ludwig, Michael P., Matthew D. Galbraith, Amanda A. Hill, et al.. (2023). Proteasome Inhibition Sensitizes Liposarcoma to MDM2 Inhibition with Nutlin-3 by Activating the ATF4/CHOP Stress Response Pathway. Cancer Research. 83(15). 2543–2556. 8 indexed citations

Hill, Amanda A., et al.. (2022). Mertk: An emerging target in cancer biology and immuno-oncology. International review of cell and molecular biology. 368. 35–59. 19 indexed citations

Wang, Diana G., Marcia N. Paddock, Mark R. Lundquist, et al.. (2019). PIP4Ks Suppress Insulin Signaling through a Catalytic-Independent Mechanism. Cell Reports. 27(7). 1991–2001.e5. 40 indexed citations

Lee‐Sherick, Alisa B., Kristen M. Jacobsen, Curtis J. Henry, et al.. (2018). MERTK inhibition alters the PD-1 axis and promotes anti-leukemia immunity. JCI Insight. 3(21). 61 indexed citations

Galbraith, Matthew D., Zdeněk Andrysík, Ahwan Pandey, et al.. (2017). CDK8 Kinase Activity Promotes Glycolysis. Cell Reports. 21(6). 1495–1506. 63 indexed citations

DeRyckere, Deborah, Alisa B. Lee‐Sherick, Amanda A. Hill, et al.. (2016). UNC2025, a MERTK Small-Molecule Inhibitor, Is Therapeutically Effective Alone and in Combination with Methotrexate in Leukemia Models. Clinical Cancer Research. 23(6). 1481–1492. 51 indexed citations

Minson, Katherine A., Amanda A. Hill, Xiaodong Wang, et al.. (2016). Bone Marrow Stromal Cell Mediated Resistance to Mertk Inhibition in Acute Leukemia. Blood. 128(22). 2819–2819. 2 indexed citations

Sullivan, Kelly D., Hannah C Lewis, Amanda A. Hill, et al.. (2016). Trisomy 21 consistently activates the interferon response. eLife. 5. 219 indexed citations

Balmus, Gabriel, Pei Xin Lim, Alessandra Cassano, et al.. (2015). HUS1 regulates in vivo responses to genotoxic chemotherapies. Oncogene. 35(5). 662–669. 8 indexed citations

10.

Lee‐Sherick, Alisa B., Weihe Zhang, Amanda A. Hill, et al.. (2015). Efficacy of a Mer and Flt3 tyrosine kinase small molecule inhibitor, UNC1666, in acute myeloid leukemia. Oncotarget. 6(9). 6722–6736. 35 indexed citations

11.

Alvarez‐Calderon, Francesca, Mark A. Gregory, Deborah DeRyckere, et al.. (2014). Tyrosine Kinase Inhibition in Leukemia Induces an Altered Metabolic State Sensitive to Mitochondrial Perturbations. Clinical Cancer Research. 21(6). 1360–1372. 56 indexed citations

12.

DeRyckere, Deborah, Amanda A. Hill, Xiaodong Wang, et al.. (2014). Abstract 1740: Development of a novel small molecule MER tyrosine kinase inhibitor with therapeutic activity in cell culture and mouse models of acute lymphoblastic leukemia. Cancer Research. 74(19_Supplement). 1740–1740. 2 indexed citations

13.

DeRyckere, Deborah, Alisa B. Lee‐Sherick, Amanda A. Hill, et al.. (2014). UNC2025, a Small Molecule MerTK and Flt3 Tyrosine Kinase Inhibitor, Decreases Disease Burden, Prolongs Survival, and Promotes Sensitivity to Chemotherapy in Xenograft Models of Acute Leukemia. Blood. 124(21). 998–998.

14.

Minson, Katherine A., Catherine C. Smith, Alisa B. Lee‐Sherick, et al.. (2014). MRX2843, a Novel Dual MerTK-FLT3 Inhibitor with Activity Against Resistance-Conferring FLT3 Mutations in Acute Myeloid Leukemia. Blood. 124(21). 3757–3757. 3 indexed citations

15.

Deek, Matthew P., et al.. (2012). Extracellular fluid conductivity analysis by dielectric spectroscopy forin vitrodetermination of cortical tissue vitality. Physiological Measurement. 33(7). 1249–1260. 2 indexed citations

16.

Deek, Matthew P., et al.. (2010). Design and implementation of a novel superfusion system forex vivocharacterization of neural tissue by dielectric spectroscopy (DS). Physiological Measurement. 32(2). 195–205. 2 indexed citations

17.

Meneilly, Graydon S. & Amanda A. Hill. (1993). Alterations in Glucose Metabolism in Patients with Alzheimer's Disease. Journal of the American Geriatrics Society. 41(7). 710–714. 67 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact